tiprankstipranks
Trending News
More News >
Metagenomi, Inc. (MGX)
NASDAQ:MGX
US Market

Metagenomi, Inc. (MGX) Stock Forecast & Price Target

Compare
887 Followers
See the Price Targets and Ratings of:

MGX Analyst Ratings

Strong Buy
4Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
Based on 4 analysts giving stock ratings to
Metagenomi,
Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MGX Stock 12 Month Forecast

Average Price Target

$10.33
▲(507.65%Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Metagenomi, Inc. in the last 3 months. The average price target is $10.33 with a high forecast of $16.00 and a low forecast of $7.00. The average price target represents a 507.65% change from the last price of $1.70.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","17":"$17","4.25":"$4.25","8.5":"$8.5","12.75":"$12.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$16.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10.33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$10.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$7.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,4.25,8.5,12.75,17],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.49,2.606153846153846,3.722307692307692,4.838461538461538,5.954615384615384,7.070769230769231,8.186923076923076,9.303076923076922,10.419230769230769,11.535384615384615,12.651538461538461,13.767692307692307,14.883846153846152,{"y":16,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.49,2.17,2.8499999999999996,3.5300000000000002,4.21,4.89,5.57,6.25,6.93,7.609999999999999,8.29,8.969999999999999,9.65,{"y":10.33,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.49,1.9138461538461538,2.3376923076923077,2.7615384615384615,3.1853846153846153,3.609230769230769,4.033076923076923,4.4569230769230765,4.88076923076923,5.304615384615384,5.728461538461539,6.1523076923076925,6.576153846153846,{"y":7,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":12,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.04,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.42,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.5,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.97,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.07,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.11,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.08,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.61,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.69,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.05,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.32,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.49,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$16.00Average Price Target$10.33Lowest Price Target$7.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on MGX
TipRanks AITipRanks
Not Ranked
TipRanks
$1.5
Hold
-11.76%
Downside
Reiterated
06/06/25
Metagenomi, Inc.'s overall stock score is primarily influenced by its strong revenue growth and recent technological advancements in genome editing, which are offset by profitability challenges and a negative valuation perspective. The technical analysis suggests a neutral market sentiment, indicating potential but cautious investor optimism.
H.C. Wainwright Analyst forecast on MGX
Mitchell KapoorH.C. Wainwright
H.C. Wainwright
$7
Buy
311.76%
Upside
Reiterated
05/27/25
Metagenomi, Inc. (MGX) Gets a Buy from H.C. Wainwright
BMO Capital Analyst forecast on MGX
Kostas BiliourisBMO Capital
BMO Capital
$8
Buy
370.59%
Upside
Reiterated
05/15/25
Wells Fargo Analyst forecast on MGX
Yanan ZhuWells Fargo
Wells Fargo
$20$16
Buy
841.18%
Upside
Reiterated
05/14/25
Metagenomi price target lowered to $16 from $20 at Wells FargoMetagenomi price target lowered to $16 from $20 at Wells Fargo
TD Cowen Analyst forecast on MGX
Joseph ThomeTD Cowen
TD Cowen
Buy
Reiterated
05/13/25
Metagenomi's Promising Gene Editing Advancements and Strategic Growth Drive Buy Rating
Jefferies
$21
Buy
1135.29%
Upside
Assigned
11/13/24
Chardan Capital Analyst forecast on MGX
Geulah LivshitsChardan Capital
Chardan Capital
$17$15
Buy
782.35%
Upside
Reiterated
08/19/24
Buy Rating Affirmed for Metagenomi Amid Strong Financials and Promising Gene Therapy Research
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on MGX
TipRanks AITipRanks
Not Ranked
TipRanks
$1.5
Hold
-11.76%
Downside
Reiterated
06/06/25
Metagenomi, Inc.'s overall stock score is primarily influenced by its strong revenue growth and recent technological advancements in genome editing, which are offset by profitability challenges and a negative valuation perspective. The technical analysis suggests a neutral market sentiment, indicating potential but cautious investor optimism.
H.C. Wainwright Analyst forecast on MGX
Mitchell KapoorH.C. Wainwright
H.C. Wainwright
$7
Buy
311.76%
Upside
Reiterated
05/27/25
Metagenomi, Inc. (MGX) Gets a Buy from H.C. Wainwright
BMO Capital Analyst forecast on MGX
Kostas BiliourisBMO Capital
BMO Capital
$8
Buy
370.59%
Upside
Reiterated
05/15/25
Wells Fargo Analyst forecast on MGX
Yanan ZhuWells Fargo
Wells Fargo
$20$16
Buy
841.18%
Upside
Reiterated
05/14/25
Metagenomi price target lowered to $16 from $20 at Wells FargoMetagenomi price target lowered to $16 from $20 at Wells Fargo
TD Cowen Analyst forecast on MGX
Joseph ThomeTD Cowen
TD Cowen
Buy
Reiterated
05/13/25
Metagenomi's Promising Gene Editing Advancements and Strategic Growth Drive Buy Rating
Jefferies
$21
Buy
1135.29%
Upside
Assigned
11/13/24
Chardan Capital Analyst forecast on MGX
Geulah LivshitsChardan Capital
Chardan Capital
$17$15
Buy
782.35%
Upside
Reiterated
08/19/24
Buy Rating Affirmed for Metagenomi Amid Strong Financials and Promising Gene Therapy Research
Stocks with the Highest Top Analyst Consensus in the General Sector
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Metagenomi, Inc.

1 Month
xxx
Success Rate
2/6 ratings generated profit
33%
Average Return
+4.27%
reiterated a xxx
rating 24 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 33.33% of your transactions generating a profit, with an average return of +4.27% per trade.
3 Months
xxx
Success Rate
4/9 ratings generated profit
44%
Average Return
-12.00%
reiterated a xxx
rating 12 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 44.44% of your transactions generating a profit, with an average return of -12.00% per trade.
1 Year
Kostas BiliourisBMO Capital
Success Rate
2/6 ratings generated profit
33%
Average Return
-37.85%
reiterated a buy rating 24 days ago
Copying Kostas Biliouris's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -37.85% per trade.
2 Years
xxx
Success Rate
2/6 ratings generated profit
33%
Average Return
-37.43%
reiterated a xxx
rating 24 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -37.43% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MGX Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
8
3
2
2
6
Buy
1
1
2
2
2
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
4
4
4
8
In the current month, MGX has received 8 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MGX average Analyst price target in the past 3 months is 10.33.
Each month's total comprises the sum of three months' worth of ratings.

MGX Financial Forecast

MGX Earnings Forecast

Next quarter’s earnings estimate for MGX is -$0.62 with a range of -$0.79 to -$0.51. The previous quarter’s EPS was -$0.68. MGX beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 60.70% of the time in the same period. In the last calendar year MGX has Outperformed its overall industry.
Next quarter’s earnings estimate for MGX is -$0.62 with a range of -$0.79 to -$0.51. The previous quarter’s EPS was -$0.68. MGX beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 60.70% of the time in the same period. In the last calendar year MGX has Outperformed its overall industry.

MGX Sales Forecast

Next quarter’s sales forecast for MGX is $8.45M with a range of $2.50M to $12.10M. The previous quarter’s sales results were $4.13M. MGX beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 55.56% of the time in the same period. In the last calendar year MGX has Outperformed its overall industry.
Next quarter’s sales forecast for MGX is $8.45M with a range of $2.50M to $12.10M. The previous quarter’s sales results were $4.13M. MGX beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 55.56% of the time in the same period. In the last calendar year MGX has Outperformed its overall industry.

MGX Stock Forecast FAQ

What is MGX’s average 12-month price target, according to analysts?
Based on analyst ratings, Metagenomi, Inc.’s 12-month average price target is 10.33.
    What is MGX’s upside potential, based on the analysts’ average price target?
    Metagenomi, Inc. has 507.65% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is MGX a Buy, Sell or Hold?
          Metagenomi, Inc. has a consensus rating of Strong Buy which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Metagenomi, Inc.’s price target?
            The average price target for Metagenomi, Inc. is 10.33. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $16.00 ,the lowest forecast is $7.00. The average price target represents 507.65% Increase from the current price of $1.7.
              What do analysts say about Metagenomi, Inc.?
              Metagenomi, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
                How can I buy shares of MGX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis